StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)

Close on Nov 17, 2026Market cap $70.84MP/E –Yield –

Coya Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Coya Therapeutics's price to sales ratio was 9.4× on Nov 11, 2026, against 27.3× a year earlier. Over the last 3 years it ranged from 9.1× to 259.1×, with a median of 17.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.4×−15.0
2025Dec 31, 202524.4×+15.2
2024Dec 31, 20249.1×–

More Coya Therapeutics figures

See a number that looks wrong?